Showing results (21-30 of 29) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 29 results.
Leukemia|September 14, 1999
Axl expression is associated with adverse prognosis and with expression of Bcl-2 and CD34 in de novo acute myeloid leukemia (AML): results from a multicenter trial of the Swiss Group for Clinical Cancer Research (SAKK)C Rochlitz, A Lohri, M Bacchi, et al.
European Journal of Haematology|October 24, 1997
Five putative drug resistance parameters (MDR1/P-glycoprotein, MDR-associated protein, glutathione-S-transferase, bcl-2 and topoisomerase IIalpha) in 57 newly diagnosed acute myeloid leukaemias. Swiss Group for Clinical Cancer Research (SAKK)A Lohri, B van Hille, M Bacchi, et al.
Schweizerische Medizinische Wochenschrift|October 26, 1985
[Clinical characteristics of immature T-type (negative E-rosette) acute lymphoblastic leukemia detected by LAU-A1 monoclonal antibody]V von Fliedner, J P Grob, D Heumann, et al.
Haematology and Blood Transfusion|January 1, 1987
Long-term results of two Swiss AML studiesC Sauter, P Alberto, W Berchtold, et al.
International Journal of Cancer|January 15, 1988
Mutation analysis of the N-ras proto-oncogene in active and remission phase of human acute leukemiasH P Senn, C Trân-Thang, A Wodnar-Filipowicz, et al.
British Journal of Haematology|April 1, 1985
Heterogeneity of Ia antigen expression on myeloblastic leukaemias: correlation with stage of maturation defined by cytochemical markersD Heumann, S Carrel, A Morell, et al.
Annals of Hematology|December 24, 1997
MTS1 expression and prognosis in acute myeloid leukemiaC F Rochlitz, A Lohri, G Sasse-Roth, et al.
British Journal of Haematology|May 1, 1994
Intensive induction/consolidation therapy without maintenance in adult acute lymphoblastic leukaemia: a pilot assessment. Working Party on Leukaemia of the Swiss Group for Epidemiologic and Clinical Cancer Research (SAKK)M Wernli, A Tichelli, V von Fliedner, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 1, 1997
Post-remission therapy of adult acute myeloid leukaemia: one cycle of high-dose versus standard-dose cytarabine. Leukaemia Project Group of the Swiss Group for Clinical Cancer Research (SAKK)M Fopp, M F Fey, M Bacchi, et al.
Pageof 3